Array BioPharma News

"Penny Stocks that Perform" picks are: Array BioPharma Inc. , ManTech International Corporation , SonicWALL, Inc.

Medidata Solutions, a leading global provider of hosted clinical development solutions, today announced that customers Wyeth Research and Array BioPharma Inc.

LOS ALTOS, Calif.-- --Developing perception-based quality assessment test and measurement tools, QoE Systems, today unveiled its Q-Master HD Video quality analyzer.

Array BioPharma Inc. today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Leerink Swann Oncology Roundtable Conference on May 20 in New York City.

The Dow jumped higher Monday, and the S&P 500 reached a high not seen in four months.

Array BioPharma Inc.'s cancer-fighting drug ARRY-543 showed promising results in a phase I clinical trial.

Array BioPharma Inc. today announced the presentation of an abstract detailing positive data for its novel, small-molecule p38 / Tie2 inhibitor, ARRY-614. In this study, ARRY-614 demonstrated the potential for potent inhibition of cytokine synthesis, including IL-6 and TNF, and anti-tumor activity in hematological cancers.

Pennyperformers.com "Penny Stocks that Perform" picks are: Atlas Pipeline Partners, L.P. , Array BioPharma Inc.

Array BioPharma Inc. today announced that eighteen abstracts have been selected for presentation at the American Association for Cancer Research Annual Meeting, being held from April 18-22, 2009, in Denver, Colorado.

31, 2008. - NORFOLK, Va.-- --Culinary Institute of Virginia, the School of Culinary Arts at ECPI College of Technology, is pleased to announce their first ever Career Education Expo to be held on Saturday, ...

BOULDER, Colo.-- --Array BioPharma Inc. today reported financial results for the second quarter of the Company's 2009 fiscal year ending December 31, 2008.

Array BioPharma Inc. today announced that its Chief Executive Officer, Robert E. Conway, will speak at the BIO CEO and Investor Conference in New York City.

Boulder-based Array BioPharma announced Friday that it has cut 40 employees, or about 10 percent of its work force.

Jan 9, 2009 - Array BioPharma Inc. today announced plans to accelerate partnering initiatives and scale back discovery research spending over the next 24 months to help ensure sustainable growth through the ...

Jan 9, 2009 - Array BioPharma Inc. has initiated dosing in healthy volunteers in a Phase 1 clinical trial with ARRY-300, a targeted small molecule MEK inhibitor.

Array BioPharma Inc. today announced that it has received its second draw of $40 million from Deerfield Management, a leading healthcare investment organization and one of Array's largest shareholders.